Overview

A Study for Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Alkermes, Inc.
Treatments:
Insulin
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human
Protamines